Abramson D, Usleber E and Märtlbauer E (1996). Determination of citrinin in barley by indirect and direct enzyme immunoassay. Journal of AOAC international, 79:1325-1329.
Abramson D, Usleber E, Martlbauer E (1995) An indirect enzyme immunoassay for the mycotoxin citrinin. Appl Environ Microbiol 61: 2007-2009
Alberts AW, Chen J, Kiron G et al. (1980). Mevinolin: a highly potent competitive inhibitor of HMG-CoA reductase and cholesterol-lowering agent. Proc Natl Acad Sci USA 77:3957-3961
Alberts AW, MacDonald JS, Til, AE et al. (1989). Lovastatin. Cardiovascular Drug Research 7: 89-109.
Alcerts AW (1988). Discovery, biochemistry and biology of lovastatin. Am J Cardiol 62:10J-15L.
Aniya Y, Yokomakura T, Yonamine M et al. (1998). Protective effect of the mold Monascus anka against acetaminophen-induced liver toxicity in rats. Japanese Journal of Pharmacology 78: 79-82.
Aniya, Y., Yokomarura, T., Yonamine, M. et al. (1999). Screening of antioxidation action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats., Gen. Pharmacol., 32:225-331.
Barnard EL (1987). A new species of Monascus from pine tissues in floride. Mycologia. 79:479-484.
Blanc PJ, Laussac JP, Le Bars J et al. (1995). Characterization of monascidin A from Monascus as citrinin. Int J Food Microbiol 27: 201-213
Brown MS. and Goldstein JL, (1984). How LDL receptors influence cholesterol and atherosclerosis. Scientific American, 251(5): 52-60.
Cannon PF, Abdullah SK and Abbas BA (1995). Two new species of Monascus from Iraq with with a key to know species of the genus. Mycol. Res. 99:659-662.
Chen MH, Johns MR (1993). “Effect of pH and nitrogen source on pigment production by Monascus purpureus, ” Appl. Microb. Biotechnol. ,Vol. 40, pp. 132-138.
Ciegler A, Vesonder RF and Jackson LK (1977). Production and biological activity of patulin and citrinin from penicillium expansum. Applied and Environmental Microbiology. 33(4):1004-1006
Dieter Wild, Gabor Tóth, and Hans-Ulrich Humpf (2002). New Monascus Metabolite Isolated from Red Yeast Rice (Angkak, Red Koji). J. Agric. Food Chem. 50, 3999-4002.
Endo A (1979). Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. Journal of Antibiotics 32: 852-854.
Endo A, Komagata D, and Shimada H (1986). Monacolin M, a new inhibitor of cholesterol biosynthesis. The Journal of Antibiotics, 39: 1670-1673.
Endo A, Kuroda M and Tusija Y (1976). ML-336, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. Journal of Antibiotics 29: 1346-1348.
Ensminger AH, Ensminger ME, Konlande JE et al. (eds.) (1994). Foods and Nutrition Encyclopedia. Second edition. Boca Raton, FL: CRC Press.
Fears R (1983). Pharmacological control of 3-Hydroxy-3-Methylglutaryl Coenzyme A reductase. In 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Sabine, J. R., Ed, 189-208, CRC Press, Inc., Boca Raton.
Fink-Gremmels J, Dresel J and Leistner L (1991). Einstaz von Monascus- extrakten als nitrat-alternative bei fleischerzeugnissen [Use of Monascus extracts as an alternative to nitrite in meat products]. Fleischwirtschaft 71: 329-331.
Fouler SG, Trivedi AB, Kitabatake N (1994) Detoxification of citrinin and ochratoxin A by hydrogen peroxide. J AOAC Int 77: 631-637
Grundy SM (1988). HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. New England Journal of Medicine 319: 24-33.
Hajjaj H, Klaébé A, Goma G, Blanc PJ, Barbier E, François J (2000). Medium-chain fatty acids affect citrinin production in the filamentous fungus Monascus ruber, Applied And Environmental Microbiology, Vol. 66, Issue 3, p.1120-1125.
Hawskworth DL, Pitt JI (1983). A new taxonomy for Monascus species based on cultural and microsopical character. Aust J Bot 31:51-61.
Jones RP and Greenfield PF (1982). Effect of carbon dixoid on yeast growth and fermentation. Enzyme Microb Technol 4:210-223.
Juzlova P, Martinkova L and Kren V (1996). Secondary metabolites of the fungus Monascus: a review. Journal of Industrial Microbiology 16: 163-170.
Juzlova P, Rezanka T, Martinkova L et al. (1996a). Long-chain fatty acids from Monascus purpureus. Phytochemistry 43: 151-153.
Kantola T, Kivistö KT and Neuvonen PJ (1998). Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clinical Pharmacology and Therapeutics 63: 397-402.
Kitabatake N, Doi E, Trivedi AB (1993) Toxicity evaluation of the mycotoxins, citrinin and ochratoxin A, using several animal cell lines. Comp Biochem Physiol C 105: 429-433
Lee YK, Chen DC, Chauvatcharin S, Seki T, and Yoshida T (1995). Production of Monascus pigments by a solid-liquid state culture method. Journal of Fermentation and Bioenginnering, Vol. 79, No. 5-516-518.
Liu B and Bau YS (1980). Fungi Pharmacopoeia (Sinica). Oakland, CA: The Kinoko Company, pp. 8-10.
Ma JY , Li YG , Ye Q et al. (2000). Constituents of Red Yeast Rice, a Traditional Chinese Food and Medicine. J. Agric. Food Chem. 48, 5220-5225.
Manzoni M, Rollini M (2002). Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl Microbiol Biotechnol 58:555-564.
Martinkova L, Patakova-Juzlova P, Kren V et al. (1999) Biological Activities of Oligeketide Pigments of Monascus purpureus. Food addit. Contam. (16)15-24.
Nil, (1995 a), SSRI: unprecedented US Growth, Scrip, 2024 : 23.
Nil, (1995 b), Yen Effect on Japan’s Pharma Market, Scrip, 2023 : 22.
Patakova-Juzlova P, Rezanka T and Viden I (1998). Identification of volatile metabolites from rice fermented by the fungus Monascus purpureus (an-kak). Folia Microbiologica 43: 407-410.
Sankawa U, Ebizuka Y, Noguchi H et al. (1983). ” Biosynthesis of citrinin in Aspergillus terrers,” Tetrahedron, Vol. 39, No. 21, pp. 3583-3591
Sharmila R, Donald CP, Thaddeus H, Michael L, Khandan K (1999). Lovastatin-madiated G1 arrest is thought inhibition of the proteasome, independent of hydroxymethyl glutary-CoA redictase. Proc. Nat. l Acad. Sci. USA, 96:7797-7802.
Su YC, Wang JJ, Lin TT and Pan TM (2003). Production of the secondary metabolites c-aminobutyric acid and monacolin K by Monascus. J. Ind. Microbiol Biotechnol, 30: 41–46
Ueno Y, Hayakawa K, Takahashi S, Oda K (1997) Purification and characterization of glutamate decarboxylase from Lactobacillus brevis IFO 12005. Biosci Biotechnol Biochem 61: 1168-1171
Wang J, Su M, Lu Z et al. (1995). Clinical trial of extract of Monascus purpureus (red yeast) in the treatment of hyperlipidemia. Chinese Journal of Experimental Therapeutics for Prepared Chinese Medicine 1: 1-5 (translation).
Wang JJ, Lee CL, Pan TM (2003). Improvement of monacolin K, α-aminobutyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601. J. Ind. Microbiol Biotechnol 30: 669–676.
Went FAFC (1895). Monascus purpureus le champignon de l`ang-quac une nouvelle thélébolée. Annales des Sciences Naturelles. Botanique et Biologie 8: 1-18.
Xie S and Duan Z (1996). Xuezhikang capsule regulates blood lipids with high efficacy: an overview of its preparation, pharmacology, toxicology, and results of clinical trials. Chinese Medical News 11: 13-14 (translation).
Yasukawa K, Takahashi M, Natori S et al. (1994). Azaphilones inhibit tumor promotion by 12-o-tetradecanoylphorbol-13-acetate, Oncology (45)108-112,
Ying J, Mao X, Ma Q et al. (1987). Icones of Medicinal Fungi from China. Beijing, China: Science Press, pg. 9.
王志傑,2003。紅麴菌二級代謝產物之生產與應用之研究,國立台灣大學微生物與生化學研究所博士論文。王雲萍、張永吉,1996。文明產物-降血脂劑 Lovastatin。化工資訊,10(4):53-57。
王蘭欣,2002。紅麴菌 Monascus pilosus 產孢與其天然色素生產之研究,朝陽科技大學應用化學系碩士論文。李俊霖,2003。提高紅麴中 monacolin K、GABA 與降低 citrinin 生成量之研究,國立台灣大學農業化學研究所碩士論文。李時珍,明朝。本草綱目,華夏出版社,1999,中國大陸。
李雲、閻雪秋、李枚牧、張茂良,1999。紅麴與桔黴素。食品與發酵工業 26(3):82-86。
林以立,2003。紅麴抗癌活性之研究,國立台灣大學農業化學研究所碩士論文。林俊杰,1996。麴之理論,製酒科技專論彙編,第十八期,169-174。林俊毅,2001。建立紅麴毒素 citrinin 酵素免疫分析法之研究,國立臺灣大學農業化學研究所碩士論文林姿岑,2000。紅麴菌二級代謝產物之醱酵生產研究-γ-胺基丁酸及monacolin K,國立台灣大學農業化學研究所碩士論文。林讚峰,1982。紅麴菌研究發展之演進。製酒科技專論彙編,第四期,66-77。林讚峰,1983。紅麴菌之鑑定及實用分類法。製酒科技專論彙編,第五期,104-113。林讚峰,1985。紅麴菌的次級代謝--聚克呔代謝,製酒科技專論彙編,第七卷,第170-187頁。林讚峰,1986。紅麴菌次級代謝物的經濟性評估及增產策略,製酒科技專論彙編,8: 81-99林讚峰,1987。利用紅麴菌生產膽固醇合成抑制劑,酒類試驗所研究年報,76年度,第157-164頁。
林讚峰,1992 a。紅麴菌在保健食品上的新用途。食品工業,24(10):41-45。林讚峰,1992 b。紅麴菌研究發展之演進。科學農業,40(3-4):193-198。林讚峰,1995。紅麴菌培養工藝及紅麴應用之演進,製酒科技專論彙編,第十七卷,第156-168頁。林讚峰,黃正財,1983。紅麴菌釀造性質之研究(一)澱粉水解酵素。酒類試驗所研究年報72 年度,157-167。
莊淑惠,2003。紅麴色素之應用,食品科學,第35卷第三期,3-8。
野崎紘一,1979。食品加工に利用される天然色素について。New Food Ind. 21(5):2-7.
陳彥霖,2003。紅麴桔黴素之生成及安全性,食品科學,第35卷第三期,30-37。
陳偉元,1990。紅麴豆腐乳香氣成分與色澤分析之研究,大葉大學食品工程研究所碩士論文。陳慶源、許薰尹,2003。紅麴菌發酵生產技術,食品科學,第35卷第三期,9-19。
黃顯宗,1985。紅麴菌研究的回顧與展望,真菌學之最近發展(曾聰徹,陳瑞青主編),國科會生物科學研究中心專刊(台北)第十二集,109-124。
鈴木秀昭,1988。加工食品へのモナスカスのについて。New Food Ind. 30(4):20-24.
編輯部(日文), 1999。 紅麴製品的桔黴素污染問題,New food industry. 41(8):10-12。
鄭子彥,2003。紅麴citrinin定量分析方法之研究,國立台灣大學農業化學研究所碩士論文。鄭顏昆,2001。甲硫胺酸與乙酸鈉對紅麴生產膽固醇合成抑制劑產量影響之研究,大葉大學食品工程研究所碩士論文樽井壓一,1993。紅麴素材的開發與利用,食品與開發,28(1): 47-50。
蕭明熙,1985。真菌代謝物之最近研究趨勢,真菌學之最近發展(曾聰徹,陳瑞青主編),國科會生物科學研究中心專刊(台北)第十二集,163-183。
蘇遠志,1999。應用微生物學,國立編譯館,華香園出版,第945-960 頁
蘇遠志,2001。紅麴製品應用與市場概況,生物產業,Vol. 12, No.3, 216-223。蘇遠志、陳文亮、方鴻源、翁浩慶、王文祥,1970。紅麴菌之菌學研究,中國農業化學會誌,8(1-2) p.46-54。